THE CORIFIX LIGAMENT ANCHOR

K973005 · Corin USA · HWC · Nov 10, 1997 · Orthopedic

Device Facts

Record IDK973005
Device NameTHE CORIFIX LIGAMENT ANCHOR
ApplicantCorin USA
Product CodeHWC · Orthopedic
Decision DateNov 10, 1997
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3040
Device ClassClass 2
AttributesTherapeutic

Indications for Use

For use in conjunction with the patient's medial hamstring tendons, namely semitendinosus and gracilis, by securing the looped tendons to the femur and tibia in order to repair damaged anterior and posterior cruciate ligaments. Relief of pain and restoration of knee finction arising from damage to anterior of posterior cruciate ligaments,

Device Story

Corifix Ligament Anchor System comprises ligament anchors, staples (claws), and bone screws; used to secure looped semitendinosus and gracilis tendons to femur and tibia for ACL/PCL repair. Dedicated ligament claw impactor used for claw insertion. System allows immediate post-operative early joint motion and weight bearing. Used by surgeons in clinical settings. Titanium construction ensures biocompatibility. Clinical benefit includes pain relief and restoration of knee function.

Clinical Evidence

Device has been in clinical use outside the USA for approximately four years with no significant post-operative problems reported. Submission supported by mechanical test data and clinical results.

Technological Characteristics

Materials: Titanium certified to BS 7252 Part 3 (ISO 5832 Part 3). Components: Ligament anchors, staples (claws), bone screws, and dedicated impactor. Dimensions: 6.5mm diameter screws. Principle: Mechanical fixation of tendon grafts to bone.

Indications for Use

Indicated for patients requiring repair of damaged anterior or posterior cruciate ligaments using medial hamstring tendons (semitendinosus and gracilis).

Regulatory Classification

Identification

A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Submission Summary (Full Text)

{0}------------------------------------------------ <973005 Name of Company: Corifix Ltd The Corinium Centre Cirencester Gloucestershire GI.7 IYJ England NOV 10 1997 Name of Device Corifix Ligament Anchor A Ligament Anchor system comprising a range of Ligament Anchors, Device Description: Ligament Staples (Claws) and Bone Screws. The devices are used in conjunction with the patient's medial hamstring tendons, namely semitendinosus and gracilis. by securing the looped tendons to the femur and tubia in order to repair damaged anterior and posterior cruciate ligaments. A dedicated Ligament Claw Impactor is used during unpaction of the Ligament Claw into the patient's femur. Each of the implantable devices is manufactured from titanium which is certified to BS 7252 Part 3 (ISO 5832 Part 3) Reconstruction of the anterior and posterior cruciate ligaments using the Corifix Ligament Anchor System allows immediate post-operative early joint motion and early weight bearing ## SUBSTANTIAL EQUIVALENCE AND SAFETY AND SUMMARY OF EFFECTIVENESS The Corifix Ligament Anchor System is substantially equivalent to the (Linvated) Concept 6.5mm Screw and Spiked Washer Anchoring Implant, - Both implants are made of titanium. a) - Both are used to anchor semitendinosus and gracilis grafts in place during ACL b) surgery. - Both utilise 6.5mm titanium cancellous screws c) - Both have a spiked washer which accepts a 6.5mm diameter screw. d) This submission is supported by mcchanical test data and clinical results confirming the device's safety and effectiveness. The device has been in clinical use outside the USA for approximately four years and no significant post-operative problems have been reported. {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a stylized eagle with three lines forming its body and wings. The eagle is facing right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular fashion around the eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Craiq Corrance President Corin U.S.A. 10500 University Center Drive, Suite 130 Tampa, Florida 33612 NOV 10 1997 Re : K973005 The Corifix Ligament Anchor Trade Name: Requlatory Class: II Product Code: HMC Dated: August 6, 1997 Received: August 13, 1997 Dear Mr. Corrance: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include reguirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (OS) inspections, the Food and Druq Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {2}------------------------------------------------ ## Page 2 - Mr. Craig Corrance This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, 3 Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ 【 【 【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 】【 | 510(k) Number (if known): | K973005 | |---------------------------|---------| |---------------------------|---------| The Corifix Ligament Anchor Device Name: __ :. ## INDICATIONS FOR USE For use in conjunction with the patient's medial hamstring tendons, namely semitendinosus and gracilis, by securing the looped tendons to the femur and tibia in order to repair damaged anterior and posterior cruciate ligaments. Relief of pain and restoration of knee finction arising from damage to anterior of posterior cruciate ligaments, (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IP NEEDED) Concurrence of CDRH, Office of Device Evaluation ACDEE Prescription Use (per 21 CFR 801.109) OR Over The Counter Use
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...